Use of a modified erythropoietin for the preparation of medicaments for the protection, restoration and enhancement of erythropoietin-responsive cells, tissues and organs

摘要

Methods and compositions are provided for protecting or enhancing an erythropoietin-responsive cell, tissue, organ or body part function or viability in vivo, in situ or ex vivo in mammals, including human beings, by systemic or local administration of an erythropoietin receptor activity modulator, such as an erythropoietin or a modified erythropoietin.